ALK inhibitors work by specifically targeting and inhibiting the ALK protein's tyrosine kinase activity. This action prevents the signaling pathways that promote tumor growth and survival. By blocking these pathways, ALK inhibitors can effectively halt the progression of cancer cells that rely on ALK mutations or rearrangements for growth.
